PRIMARY SCLEROSING CHOLANGITIS
Clinical trials for PRIMARY SCLEROSING CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SCLEROSING CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY SCLEROSING CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common arthritis drug ease a rare liver disease?
Disease control CompletedThis study tested whether sulfasalazine, a drug used for arthritis and inflammatory bowel disease (IBD), can help people with primary sclerosing cholangitis (PSC), a rare liver condition. About 32 adults with both PSC and IBD took either sulfasalazine or a placebo for several mon…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug shows promise for rare liver disease in early trial
Disease control CompletedThis study tested a new medicine called PLN-74809 in 121 adults with primary sclerosing cholangitis (PSC) and suspected liver scarring. The main goal was to check if the drug is safe and tolerable at different doses compared to a placebo. Researchers also measured how much of the…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: PHASE2 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
New MRI scan put to the test for liver disease
Knowledge-focused CompletedThis study checked if a special MRI scan called LiverMultiScan gives the same results when a person is scanned twice on the same machine or on different machines. 61 adults with various liver diseases took part. The goal was to see if the scan reliably measures liver fat, iron, a…
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Sponsor: Perspectum • Aim: Knowledge-focused
Last updated May 17, 2026 04:18 UTC
-
Diet showdown: vegan vs. Carb-Restricted for rare liver disease
Knowledge-focused CompletedThis study tested two different diets—a vegan/low-sulfur diet and the specific carbohydrate diet—in 20 adults with primary sclerosing cholangitis (PSC), a rare liver disease. Participants followed their assigned diet for 8 weeks with support from dietitians. The main goal was to …
Matched conditions: PRIMARY SCLEROSING CHOLANGITIS
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 04:13 UTC